4-((1E)-2-(6-(2-)2-(2-FLUOROETHOXY)ETHOXY)ETHOXY)PYRIDIN-3-YL)ETHENYL)-N-METHYLBENZENAMINE
Vascular Cognitive Impairment, Alzheimer's Disease, Fronto-temporal Dementia
Chang Gung Memorial HospitalSmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Vascular Cognitive Impairment, Alzheimer's Disease, Fronto-temporal Dementia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Pmpbb3 Chang Gung Memorial Hospital | Phase 2 | CCC |
Same molecule, other indications
4-((1E)-2-(6-(2-)2-(2-FLUOROETHOXY)ETHOXY)ETHOXY)PYRIDIN-3-YL)ETHENYL)-N-METHYLBENZENAMINE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →